EFFECTS OF EXTRACORPOREAL MEMBRANE-OXYGENATION ON MORPHINE PHARMACOKINETICS IN INFANTS

被引：45
|
作者：
DAGAN, O
KLEIN, J
BOHN, D
KOREN, G
机构：
[1] HOSP SICK CHILDREN,DEPT CRIT CARE,TORONTO M5G 1X8,ON,CANADA
[2] HOSP SICK CHILDREN,DEPT PEDIAT,DIV CLIN PHARMACOL TOXICOL,TORONTO M5G 1X8,ON,CANADA
[3] HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ON,CANADA
[4] UNIV TORONTO,DEPT PEDIAT,TORONTO,ON,CANADA
[5] UNIV TORONTO,DEPT PHARMACOL,TORONTO,ON,CANADA
来源：
CRITICAL CARE MEDICINE | 1994年 / 22卷 / 07期
关键词：
EXTRACORPOREAL MEMBRANE OXYGENATION; MORPHINE; INFANTS; PHARMACOKINETICS; PHARMACODYNAMICS; SEDATION; DRUG METABOLISM; OPIATES; CRITICAL ILLNESS; PHARMACOLOGY; INTENSIVE CARE UNIT; PEDIATRIC;
D O I：
10.1097/00003246-199407000-00008
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Objectives: To study the effect of extracorporeal membrane oxygenation (ECMO) on the pharmacokinetics of morphine in infants. Design: A prospective, comparative study of morphine pharmacokinetics during and after ECMO. Setting: The pediatric intensive care unit at a children's hospital. Patients: Seven infants, aged 1 day to 12 months, requiring ECMO. Intervention: Infusion of morphine. Measurement and Main Results: Steady-state concentrations of morphine were used to generate a morphine clearance rate. Plasma clearance rate of morphine increased from 0.574 +/- 0.3 L/kg/hr to 1.058 +/- 0.727 L/kg/hr after discontinuation of ECMO (p <.01). Two infants experienced a clinical picture consistent with opioid withdrawal. Conclusion: Infants requiring morphine after ECMO may require higher dose rates to maintain adequate sedation.
引用
收藏
页码：1099 / 1101
页数：3
相关论文
共 50 条
  • [1] VANCOMYCIN PHARMACOKINETICS IN INFANTS UNDERGOING EXTRACORPOREAL MEMBRANE-OXYGENATION
    HOIE, EB
    SWIGART, SA
    LEUSCHEN, MP
    WILLETT, LD
    BOLAM, DL
    GOODRICH, PD
    BUSSEY, ME
    NELSON, RM
    CLINICAL PHARMACY, 1990, 9 (09): : 711 - 715
  • [2] PHARMACOKINETICS OF GENTAMICIN IN NEONATES ON EXTRACORPOREAL MEMBRANE-OXYGENATION
    SOUTHGATE, WM
    DIPIRO, JT
    ROBERTSON, AF
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) : 817 - 819
  • [3] SELECTION OF INFANTS FOR EXTRACORPOREAL MEMBRANE-OXYGENATION (ECMO)
    BEDARD, MP
    SPLITGERBER, F
    CULLEN, M
    BOLLINGER, RO
    ARRINDEL, E
    KLEIN, MD
    POLAND, RL
    CLINICAL RESEARCH, 1985, 33 (04): : A910 - A910
  • [4] OUTCOME OF INFANTS TREATED WITH EXTRACORPOREAL MEMBRANE-OXYGENATION
    TURBOW, R
    RAMOS, AD
    PLATZKER, ACG
    NIELD, T
    CLINICAL RESEARCH, 1989, 37 (01): : A174 - A174
  • [5] INCIDENCE OF HYPERTENSION IN INFANTS ON EXTRACORPOREAL MEMBRANE-OXYGENATION
    GOLDBERG, AK
    HOWELL, CG
    KANTO, WP
    CLINICAL RESEARCH, 1987, 35 (01): : A76 - A76
  • [6] CHOLESTASIS IN INFANTS SUPPORTED WITH EXTRACORPOREAL MEMBRANE-OXYGENATION
    SHNEIDER, B
    MALLER, E
    VANMARTER, L
    OROURKE, PP
    JOURNAL OF PEDIATRICS, 1989, 115 (03): : 462 - 465
  • [7] IS IT SAFE TO TRANSPORT INFANTS FOR EXTRACORPOREAL MEMBRANE-OXYGENATION
    BUTT, W
    MCDOUGALL, P
    SHANN, F
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 1990, 26 (05) : 286 - 286
  • [8] INCIDENCE OF HYPERTENSION IN INFANTS ON EXTRACORPOREAL MEMBRANE-OXYGENATION
    BOEDY, RF
    GOLDBERG, AK
    HOWELL, CG
    HULSE, E
    EDWARDS, EG
    KANTO, WP
    JOURNAL OF PEDIATRIC SURGERY, 1990, 25 (02) : 258 - 261
  • [9] EFFECT OF EXTRACORPOREAL MEMBRANE-OXYGENATION ON TOBRAMYCIN PHARMACOKINETICS IN SHEEP
    MOLLER, JC
    GILMAN, JT
    KEARNS, GL
    SUSSMANE, JB
    RASZYNSKI, A
    WOLFSDORF, J
    REED, MD
    CRITICAL CARE MEDICINE, 1992, 20 (10) : 1454 - 1458
  • [10] PHARMACOKINETICS OF CEFOTAXIME AND AMOXICILLIN IN NEONATES ON EXTRACORPOREAL MEMBRANE-OXYGENATION
    VANDENANKER, JN
    VERNOOII, J
    SCHOEMAKER, RC
    VOGEL, M
    GOESSENS, WHF
    TIBBOEL, D
    PEDIATRIC RESEARCH, 1994, 35 (04) : A90 - A90
12345